BPTH · Bio-Path Holdings, Inc. · Financials
$0.13
-0.08 (-38.10%)
At close · Feb 19
Return incl. dividend (before tax)
Q3 2024 earnings call transcript
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company’s available cash and cash equivalents of $0.1 million at March 31, 2026 will not be sufficient to fund liquidity and capital expenditure requirements for the next 12 months from the date of issuance of these consolidated financial statements. Therefore, substantial doubt exists about the Company’s ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Market Cap
$1.51M
Shares
50.30M
Volume · Feb 19
1.56M
Avg daily vol (3M)
2.45M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$0
-100%
FY2018
Net Income
-$9.89M
+38.5%
FY2024
Operating Margin
-24232.43%
+40959.9pp
FY2017
Diluted EPS
-$4.12
+87.7%
FY2024
Operating Cash Flow
-$10.58M
+8.3%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | $0 | $37K | $13K | $0 | $0 | $0 | $0 | $0 | — | |
| — | $7.3M | $11.61M | $9.17M | $5.91M | $6.58M | $4.59M | $4.6M | $5.48M | $5.47M | $3.02M | $1.63M | $1.52M | $1.13M | — | — | |
| — | $4.7M | $4.24M | $4.74M | $4.53M | $4.33M | $4.11M | $3.38M | $3.52M | $3.01M | $2.47M | $2.72M | $1.63M | $986.1K | $1.22M | $1.13M | |
| — | — | — | — | — | — | $0 | $161K | — | — | — | $1.25M | $1.09M | $928.23K | $791.46K | — | |
| — | $11.99M | $15.84M | $13.9M | $10.44M | $10.91M | $8.69M | $8.59M | $9M | $8.49M | $5.49M | $4.54M | $3.27M | $2.58M | $2.37M | $2.33M | |
| — | -$11.99M | -$15.84M | -$13.9M | -$10.44M | -$10.91M | -$8.69M | -$8.59M | -$8.97M | -$8.48M | -$5.49M | -$4.54M | -$3.27M | -$2.58M | -$2.37M | -$2.33M | |
| — | — | — | — | — | — | — | — | -24232.43% | -65192.31% | — | — | — | — | — | — | |
| — | $14K | $36K | $33K | $3000 | $26K | $94K | $7000 | $9000 | $12K | $18K | $23K | $4037 | $779 | $2907 | $1302 | |
| — | $2.1M | -$235K | $33K | $3000 | $26K | $94K | $7000 | $1.94M | $1.73M | $18K | $23K | $3227 | $142 | $2271 | $244.93K | |
| — | -$9.89M | -$16.08M | -$13.87M | -$10.44M | -$10.88M | -$8.6M | -$8.58M | -$7.02M | -$6.75M | -$5.47M | -$4.56M | -$3.27M | -$2.58M | -$2.36M | -$2.08M | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| — | -$9.89M | -$16.08M | -$13.87M | -$10.44M | -$10.88M | -$8.6M | -$8.58M | -$7.02M | -$6.75M | -$5.47M | -$4.52M | -$3.27M | -$2.58M | -$2.36M | -$2.08M | |
| — | — | — | — | — | — | — | — | -18981.08% | -51923.08% | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | -$8.58M | -$8.06M | -$6.75M | — | — | — | — | — | — | |
| USD/shares | $0.97 | -$4.12 | -$33.63 | -$38.12 | -$31.00 | -$56.60 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$4.12 | -$33.63 | -$38.12 | -$31.00 | -$56.60 | — | — | — | — | — | — | — | — | — | — |
| shares | — | 2.4M | 478K | 364K | 336.25K | 192.35K | 132.85K | 29.85K | 25.2K | 463.5K | 4.49M | 4.46M | 3.57M | 2.97M | 2.69M | — |
| shares | — | 2.4M | 478K | 364K | 336.25K | 192.35K | 132.85K | 29.85K | 25.2K | 463.5K | 4.49M | 4.46M | 3.57M | 2.97M | 2.69M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of notes payable | 2026-03-31 | USD 511,000 | 10-Q filed 2026-05-20 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.